1-2 of 2
D. de Zeeuw
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Is Doubling of Serum Creatinine a Valid Clinical ‘Hard’ Endpoint in Clinical Nephrology Trials?

Available to Purchase
Subject Area:
Nephrology
H.J. Lambers Heerspink, V. Perkovic, D. de Zeeuw
Journal: Nephron Clinical Practice
Nephron Clinical Practice (2011) 119 (3): c195–c199.
https://doi.org/10.1159/000327614
Published Online: 11 August 2011
View articletitled, Is Doubling of Serum Creatinine a Valid Clinical ‘Hard’ Endpoint in Clinical Nephrology Trials?
Open the PDF for Is Doubling of Serum Creatinine a Valid Clinical ‘Hard’ Endpoint in Clinical Nephrology Trials? in another window
Journal Articles

Dual RAS Therapy Not on Target, but Fully Alive

Available to Purchase
Subject Area:
Nephrology
H.J. Lambers Heerspink, D. de Zeeuw
Journal: Nephron Clinical Practice
Nephron Clinical Practice (2010) 116 (2): c137–c142.
https://doi.org/10.1159/000315882
Published Online: 01 June 2010
View articletitled, Dual RAS Therapy Not on Target, but Fully Alive
Open the PDF for Dual RAS Therapy Not on Target, but Fully Alive in another window